Science Has Partly Outgrown Nobel's Vision Of The Prizes

The pioneering contributions to lepton physics, atmospheric chemistry, and developmental biology honored by this year's Nobel Prizes were all made at least some 15 or 20 years ago. This illustrates a dilemma the Nobel committees are faced with every year in the selection of the prize winners. On the one hand, the committees have to follow, as far as possible, Nobel's intention to award the prize to those who, "during the preceding year," by their scientific achievements, have conferred the gre

Written byBib Lindahl
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

On the one hand, the committees have to follow, as far as possible, Nobel's intention to award the prize to those who, "during the preceding year," by their scientific achievements, have conferred the greatest benefit on mankind. On the other hand, the committees have to make sure that the achievements have been well tested and gained acceptance in the scientific community. And, since original and wide-ranging achievements seldom win immediate acceptance, but more often are met with resistance, these two criteria-recency and acceptance through corroboration-tend to clash. It may, of course, also take a considerable time before it is possible to determine the merits, in terms of benefit to mankind, of a scientific achievement.

In order to safeguard a high standard of the selection process, the statutes of the Nobel Foundation (dated June 29, 1900) allow for exceptions to the criterion "during the preceding year." The statutes provide "that the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies